CorporateOne Goal, 50 Brands: Inside the Scramble for India’s Post-Patent Semaglutide MarketBY Shashank Bhatt
IndustryHow Indian Pharma Is Building a Sustainability Framework for a Greener FutureBY Ramesh Swaminathan
NewsAllegations Of Death By Indian Cough Syrups May Kill Indian Pharma Sector BY Outlook Business Desk